Defendant Name: Fresenius Medical Care AG & Co. KGaA 

Defendant Type: Public Company
SIC Code: 2834
CUSIP: 35802910

Document Reference: 34-85468

Document Details

Legal Case Name In the Matter of Fresenius Medical Care AG & Co. KGaA
Document Name Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
Document Date 29-Mar-2019
Document Format Administrative Proceeding
File Number 3-19126
AAER 4033
Allegation Type Foreign Corrupt Practices Act
Document Summary On March 29, 2019, the SEC issued an order against Fresenius Medical Care AG & Co. KGaA stating: "This matter concerns violations of the anti-bribery, books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act of 1977 (the "FCPA") [...] by FMC, a world-wide provider of products and services for individuals with chronic kidney failure headquartered in Bad Homburg, Germany."

Disgorgement & Penalty Information

Resolutions
Cease and Desist Order
Compliance Related Independent Consultant
Other Compliance Related Undertaking
Cooperation Before the Resolution
Remedial Acts or Efforts Before the Resolution
Self Reporting to SEC
Monetary Penalties:

Disgorgement

Individual:     $135,000,000.00 Shared:    

Pre-Judgment Interest

Individual:     $12,000,000.00 Shared:    

Total Penalty

Individual:     $147,000,000.00 Shared:    

Related Documents:

2019-48 29-Mar-2019 Press Release--Administrative Proceeding
SEC Charges Medical Device Company With FCPA Violations
The SEC stated that: "Fresenius Medical Care AG & Co KGaA (FMC) has agreed to pay more than $231 million to resolve parallel SEC and U.S. Department of Justice investigations related to its violations of the Foreign Corrupt Practices Act (FCPA) across multiple countries for nearly a decade."